Scholarlink

Background <p>It is known that an inflammatory response plays a key role in COVID-19 pathogenesis. An exacerbated inflammatory response can increase oxidative stress in cells. This study aimed to investigate the effects of COVID-19 on parameters of oxidative stress including non-protein thiol antioxidants (NPSH), protein thiols (PSH), total antioxidant capacity (TAC), advanced oxidation protein products (AOPP), myeloperoxidase (MPO), thiobarbituric acid reactive substances (TBARS), ascorbic acid, and reactive oxygen species (ROS) in plasma collected four to six weeks after the diagnosis.</p> Methods <p>This cross-sectional study included a sex-matched sample of 296 adult individuals with 112 positives (cases) and 184 negatives (controls) for COVID-19. Oxidative stress parameters were peripherally analyzed according to previous methods.</p> Results <p>The results showed a decrease in NPSH (<i>p</i> = 0.004), TAC (<i>p</i> = 0.005), ROS (<i>p</i> &lt; 0.001), and ascorbic acid (<i>p</i> &lt; 0.001) in cases. TBARS were higher in moderate and severe cases of COVID-19 compared to asymptomatic and mild cases (<i>p</i> = 0.049). AOPP, PSH, and MPO were not significantly different between cases and controls. In the total sample, individuals who self-reported using medication to prevent or treat COVID-19 showed decreased NPSH (<i>p</i> = 0.034), TAC (<i>p</i> = 0.020), ascorbic acid (<i>p</i> = 0.010), and ROS (<i>p</i> = 0.001) compared to those who self-reported not using medication to prevent or treat COVID-19.</p> Conclusions <p>In conclusion, individuals with COVID-19 had decreased antioxidant status. Furthermore, disease severity was associated with more lipid damage. Antioxidant therapies may be essential to prevent the impacts of COVID-19.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of COVID-19 and medication used for treatment and symptom prevention on the antioxidant status

  • 期刊论文

  • 发表日期：

    2025年2月3日

查看全文
  • Laura A. Borba,
  • Getúlio Antonio de Freitas Filho,
  • Taiane de Azevedo Cardoso,
  • Camila O. Arent,
  • Flávia S. Niero,
  • Lucas C. Pedro,
  • Caion A. Rodrigues,
  • Lara R. Cichella,
  • Margarete D. Bagatini,
  • Gabriela Gonçalves de Oliveira,
  • Gilnei Bruno da Silva,
  • Daiane Manica,
  • Zuleide Maria Ignácio,
  • João Quevedo,
  • Luciane B. Ceretta,
  • Gislaine Z. Réus

摘要

Background

It is known that an inflammatory response plays a key role in COVID-19 pathogenesis. An exacerbated inflammatory response can increase oxidative stress in cells. This study aimed to investigate the effects of COVID-19 on parameters of oxidative stress including non-protein thiol antioxidants (NPSH), protein thiols (PSH), total antioxidant capacity (TAC), advanced oxidation protein products (AOPP), myeloperoxidase (MPO), thiobarbituric acid reactive substances (TBARS), ascorbic acid, and reactive oxygen species (ROS) in plasma collected four to six weeks after the diagnosis.

Methods

This cross-sectional study included a sex-matched sample of 296 adult individuals with 112 positives (cases) and 184 negatives (controls) for COVID-19. Oxidative stress parameters were peripherally analyzed according to previous methods.

Results

The results showed a decrease in NPSH (p = 0.004), TAC (p = 0.005), ROS (p < 0.001), and ascorbic acid (p < 0.001) in cases. TBARS were higher in moderate and severe cases of COVID-19 compared to asymptomatic and mild cases (p = 0.049). AOPP, PSH, and MPO were not significantly different between cases and controls. In the total sample, individuals who self-reported using medication to prevent or treat COVID-19 showed decreased NPSH (p = 0.034), TAC (p = 0.020), ascorbic acid (p = 0.010), and ROS (p = 0.001) compared to those who self-reported not using medication to prevent or treat COVID-19.

Conclusions

In conclusion, individuals with COVID-19 had decreased antioxidant status. Furthermore, disease severity was associated with more lipid damage. Antioxidant therapies may be essential to prevent the impacts of COVID-19.